Skip to content

Dear Family and Friends,

Greetings! We are pleased to inform you of our transition of kidney health supplement Renadyl to a Live Biotherapeutic Product (LBP) drug category for medical reimbursement reasons. This improved version is known as US APR-2020.

Excellent and Unique Opportunity! US FDA/CBER Approved RCT To Delay Dialysis with Probiotics US-APR 2020 Phase 2B, Multi-site CKD Stage 4 (N=630) Oral and Safe Intestinal Dialysis

In this regard, if you or your friends are interested in exploring the opportunity to be a participant, in this unique clinical trial, please contact the Medical Director at clinicaltrials@kibowbiotech.com

Are you interested in knowing more information?

As we proceed with clinical trials and until the launch of the product as a drug, if you are hesitant to participate you can still avail yourself the opportunity to buy our Kidney health supplement Renadyl™(www.renadyl.com) directly from our online store. If any questions contact our customer service info@kibowbiotech.com or +1.888.271.2560 (US).
 
With warmest regards,
Dr. Rangan
Managing Director – Kibow Biotech, Inc.
4781 West Chester Pike | Newtown Square, PA 19073 
Mobile: 215-510-3575 | Off: 610-353-5130, Ext 222 | Fax: 610-353-5110 
We have recently published our study on Longdom Publishing SL with some very positive reviews from global readers.
Please click to read:

Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV (CKD), for study details,please click to review:

Kibow Pharmaceuticals, LLC | www.kibowpharma.com | Phone: +1.610.353.5130